These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8330413)

  • 1. Tolerance limits for short-term analytical bias and analytical imprecision derived from clinical assay specificity.
    Klee GG
    Clin Chem; 1993 Jul; 39(7):1514-8. PubMed ID: 8330413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical goals developed from the inherent error of medical tests.
    Ross JW; Fraser MD
    Clin Chem; 1993 Jul; 39(7):1481-93; discussion 1493-4. PubMed ID: 8330410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical goals for the estimation of non-Gaussian reference intervals.
    Hyltoft Petersen P; Gowans EM; Blaabjerg O; Hørder M
    Scand J Clin Lab Invest; 1989 Dec; 49(8):727-37. PubMed ID: 2617130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valid analytical performance specifications for combined analytical bias and imprecision for the use of common reference intervals.
    Hyltoft Petersen P; Lund F; Fraser CG; Sandberg S; Sölétormos G
    Ann Clin Biochem; 2018 Sep; 55(5):612-615. PubMed ID: 29310466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art.
    Haeckel R; Wosniok W
    Clin Chem Lab Med; 2011 Apr; 49(4):623-35. PubMed ID: 21345158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical performance specifications for changes in assay bias (Δbias) for data with logarithmic distributions as assessed by effects on reference change values.
    Petersen PH; Lund F; Fraser CG; Sölétormos G
    Ann Clin Biochem; 2016 Nov; 53(6):686-691. PubMed ID: 27147623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conceptual model for establishing tolerance limits for analytic bias and imprecision based on variations in population test distributions.
    Klee G
    Clin Chim Acta; 1997 Apr; 260(2):175-88. PubMed ID: 9177912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprint of "Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits".
    Hyltoft Petersen P; Klee GG
    Clin Chim Acta; 2014 May; 432():127-34. PubMed ID: 24747109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating test methods by estimating total error.
    Chinchilli VM; Miller WG
    Clin Chem; 1994 Mar; 40(3):464-71. PubMed ID: 8131284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical goals for interference.
    Fuentes-Arderiu X; Fraser CG
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():393-5. PubMed ID: 1892351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving standard deviation and moving sum of outliers as quality tools for monitoring analytical precision.
    Liu J; Tan CH; Badrick T; Loh TP
    Clin Biochem; 2018 Feb; 52():112-116. PubMed ID: 29107011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical goal-setting for monitoring patients when two analytical methods are used.
    Petersen PH; Fraser CG; Westgard JO; Larsen ML
    Clin Chem; 1992 Nov; 38(11):2256-60. PubMed ID: 1424120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of criteria for the evaluation of reference method values.
    Stöckl D; Reinauer H
    Scand J Clin Lab Invest Suppl; 1993; 212():16-8. PubMed ID: 8465146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of a generally applicable model for the evaluation of uncertainty of measurement in clinical chemistry.
    Kristiansen J
    Clin Chem Lab Med; 2001 Oct; 39(10):920-31. PubMed ID: 11758604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Certification of cholesterol measurements by the National Reference Method Laboratory Network with routine clinical specimens: effects of network laboratory bias and imprecision.
    Bennett ST; Eckfeldt JH; Belcher JD; Connelly DP
    Clin Chem; 1992 May; 38(5):651-7. PubMed ID: 1582015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area.
    Gowans EM; Hyltoft Petersen P; Blaabjerg O; Hørder M
    Scand J Clin Lab Invest; 1988 Dec; 48(8):757-64. PubMed ID: 3238321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partly nonparametric approach for determining the limit of detection.
    Linnet K; Kondratovich M
    Clin Chem; 2004 Apr; 50(4):732-40. PubMed ID: 14764644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits.
    Hyltoft Petersen P; Klee GG
    Clin Chim Acta; 2014 Mar; 430():1-8. PubMed ID: 24362233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing quality-control systems to detect maximum clinically allowable analytical errors.
    Linnet K
    Clin Chem; 1989 Feb; 35(2):284-8. PubMed ID: 2914374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeatability imprecision from analysis of duplicates of patient samples and control materials.
    Kallner A; Theodorsson E
    Scand J Clin Lab Invest; 2020 May; 80(3):210-214. PubMed ID: 31899972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.